Pan Ma

1.6k total citations
30 papers, 753 citations indexed

About

Pan Ma is a scholar working on Immunology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Pan Ma has authored 30 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Oncology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Pan Ma's work include Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (4 papers). Pan Ma is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (4 papers). Pan Ma collaborates with scholars based in China, United States and Germany. Pan Ma's co-authors include Yuguang Du, Chao Yu, Xuefang Bai, Yuguang Du, Kory J. Lavine, Qingsong Xu, Hongtao Liu, Peng Wei, Hua Tao and Lulu Lai and has published in prestigious journals such as Circulation, Circulation Research and Cancer Research.

In The Last Decade

Pan Ma

29 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pan Ma China 16 293 240 165 158 120 30 753
Jingjing Xu China 15 554 1.9× 294 1.2× 106 0.6× 98 0.6× 34 0.3× 30 1.1k
Chunping Liu China 14 256 0.9× 178 0.7× 61 0.4× 31 0.2× 32 0.3× 30 531
Thangirala Sudha United States 23 655 2.2× 149 0.6× 214 1.3× 129 0.8× 56 0.5× 46 1.2k
Yuxue Zhang China 12 270 0.9× 277 1.2× 136 0.8× 92 0.6× 8 0.1× 26 905
Faten Zahran Egypt 16 230 0.8× 89 0.4× 58 0.4× 98 0.6× 16 0.1× 70 947
Septelia Inawati Wanandi Indonesia 14 390 1.3× 55 0.2× 136 0.8× 76 0.5× 22 0.2× 116 778
Lina Gao China 17 475 1.6× 143 0.6× 83 0.5× 42 0.3× 22 0.2× 35 939
良樹 鷹津 China 15 344 1.2× 84 0.3× 67 0.4× 43 0.3× 219 1.8× 30 869
Hua Tang China 18 395 1.3× 200 0.8× 89 0.5× 118 0.7× 6 0.1× 41 1.1k
Chenxi Yang China 16 308 1.1× 70 0.3× 63 0.4× 132 0.8× 69 0.6× 45 763

Countries citing papers authored by Pan Ma

Since Specialization
Citations

This map shows the geographic impact of Pan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Ma more than expected).

Fields of papers citing papers by Pan Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Ma. The network helps show where Pan Ma may publish in the future.

Co-authorship network of co-authors of Pan Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Pan Ma. A scholar is included among the top collaborators of Pan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pan Ma. Pan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yong, Pan Ma, Kuo-Hsun Wen, et al.. (2025). Tracking Early Cavitation in i PP: Insights from SEM During Uniaxial Stretching. Macromolecular Rapid Communications. 46(16). e2500186–e2500186. 1 indexed citations
2.
Pérez‐Camargo, Ricardo A., Pan Ma, Ying Zhao, et al.. (2024). Impact of Long-Chain Branching on Polypropylene Nucleation and Crystallization over a Wide Temperature Range without the Influence of Shear. Macromolecules. 57(24). 11599–11613. 4 indexed citations
3.
Lou, Lan‐Lan, Lisa Detering, Hannah Luehmann, et al.. (2024). Visualizing Immune Checkpoint Inhibitors Derived Inflammation in Atherosclerosis. Circulation Research. 135(10). 990–1003. 10 indexed citations
4.
He, Yan‐Bing, et al.. (2024). Liraglutide promotes osteogenic differentiation of mesenchymal stem cells by inhibiting M1 macrophage polarization and CXCL9 release in vitro. Molecular and Cellular Endocrinology. 597. 112441–112441. 4 indexed citations
5.
Zhai, Yirui, Yongming Zhang, Haïyan Zhou, et al.. (2024). Problem-based learning on the WeChat public platform in radiation oncology residency training programs. BMC Medical Education. 24(1). 1300–1300. 2 indexed citations
6.
Amrute, Junedh, Lulu Lai, Pan Ma, et al.. (2023). Defining cardiac functional recovery in end-stage heart failure at single-cell resolution. Nature Cardiovascular Research. 2(4). 399–416. 28 indexed citations
8.
Feng, Guoshuai, Geetika Bajpai, Pan Ma, et al.. (2022). CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells. Circulation. 145(10). 765–782. 78 indexed citations
9.
Liu, Jing, Pan Ma, Lulu Lai, et al.. (2022). Transcriptional and Immune Landscape of Cardiac Sarcoidosis. Circulation Research. 131(8). 654–669. 39 indexed citations
10.
Cao, Hong, Ni Chen, Ruoqi Wang, et al.. (2022). Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells. Cancer Research. 82(13). 2472–2484. 7 indexed citations
11.
Verma, Amanda, Olakanmi Olagoke, Jonathan D. Moreno, et al.. (2022). SARS-CoV-2–Associated Myocarditis: A Case of Direct Myocardial Injury. Circulation Heart Failure. 15(3). e008273–e008273. 8 indexed citations
12.
Ma, Pan, Yue Qin, Hong Cao, et al.. (2020). Temporary blockade of interferon-γ ameliorates doxorubicin-induced cardiotoxicity without influencing the anti-tumor effect. Biomedicine & Pharmacotherapy. 130. 110587–110587. 8 indexed citations
13.
Ma, Juan, et al.. (2019). Bispecific anti-CD3 x anti-B7-H3 antibody mediates T cell cytotoxic ability to human melanoma in vitro and in vivo. Investigational New Drugs. 37(5). 1036–1043. 18 indexed citations
14.
Ma, Juan, Jing Ge, Xin Xue, et al.. (2018). Targeting bladder cancer using activated T�cells armed with bispecific antibodies. Oncology Reports. 39(3). 1245–1252. 6 indexed citations
15.
Ma, Pan, Qiang He, Wei Li, et al.. (2015). Anti-CD3 x EGFR bispecific antibody redirects cytokine-induced killer cells to glioblastoma in vitro and in vivo. Oncology Reports. 34(5). 2567–2575. 16 indexed citations
16.
Li, Xiaomei, Changzhen Liu, Juan Ma, et al.. (2015). Expansion of NK cells from PBMCs using immobilized 4-1BBL and interleukin-21. International Journal of Oncology. 47(1). 335–342. 27 indexed citations
17.
Ma, Juan, Huamin Han, Changzhen Liu, et al.. (2014). The immunostimulatory effects of retinoblastoma cell supernatant on dendritic cells. Protein & Cell. 5(4). 307–316. 14 indexed citations
18.
Han, Huamin, Juan Ma, Keming Zhang, et al.. (2014). Bispecific anti-CD3 x anti-HER2 antibody mediates T cell cytolytic activity to HER2-positive colorectal cancer in vitro and in vivo. International Journal of Oncology. 45(6). 2446–2454. 16 indexed citations
19.
Ma, Pan, Qingsong Xu, Qunhua Bai, et al.. (2012). Chitosan oligosaccharides suppress production of nitric oxide in lipopolysaccharide-induced N9 murine microglial cells in vitro. Glycoconjugate Journal. 29(5-6). 285–295. 42 indexed citations
20.
Xu, Qingsong, Pan Ma, Weiting Yu, et al.. (2009). Chitooligosaccharides Protect Human Embryonic Hepatocytes Against Oxidative Stress Induced by Hydrogen Peroxide. Marine Biotechnology. 12(3). 292–298. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026